Economic Evaluation of Single versus Combination Immuno-Oncology Therapies: Application of a Novel Modelling Approach in Metastatic Melanoma
Eddie J Gibson,1 Najida Begum,1 Ian Koblbauer,1 George Dranitsaris,2 Danny Liew,3 Phil McEwan,4 Yong Yuan,5 Ariadna Juarez-Garcia,6 David Tyas,6 Clive Pritchard1 1Wickenstones Ltd, Abingdon, UK; 2Augmentium Pharma Consulting Inc., Toronto, ON, Canada; 3School of Public Health and Preventive Medicine...
Main Authors: | Gibson EJ, Begum N, Koblbauer I, Dranitsaris G, Liew D, McEwan P, Yuan Y, Juarez-Garcia A, Tyas D, Pritchard C |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-05-01
|
Series: | ClinicoEconomics and Outcomes Research |
Subjects: | |
Online Access: | https://www.dovepress.com/economic-evaluation-of-single-versus-combination-immuno-oncology-thera-peer-reviewed-article-CEOR |
Similar Items
-
Healthcare cost comparison analysis of nivolumab in combination with ipilimumab versus nivolumab monotherapy and ipilimumab monotherapy in advanced melanoma
by: Ravi Potluri, et al.
Published: (2019-07-01) -
Modeling the economic outcomes of immuno-oncology drugs: alternative model frameworks to capture clinical outcomes
by: Gibson EJ, et al.
Published: (2018-03-01) -
The lord of the entire world : Lord Jesus, a challenge to Lord Caesar?
by: Fantin, Joseph D.
Published: (2007) -
Expert evidence in criminal proceedings : a comparative study (English adversarial and Libyan inquisitorial systems)
by: Abu-Baker Ben-Younis, Huda M.
Published: (2005) -
3-D content-based retrieval and classification with applications to museum data
by: Goodall, Simon
Published: (2007)